We've found
184,457
clinical trials
Urothelial Cancer Clinical Trial
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Volunteers Clinical Trial
A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.
Status: Enrolling,
Phase
I
Updated: 12/20/2016
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment Resistant Major Depressive Disorder Clinical Trial
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Cystic Fibrosis Clinical Trial
Standardized Treatment of Pulmonary Exacerbations II
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Complex Regional Pain Syndrome (CRPS) Clinical Trial
TARGET Post-Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Complex Regional Pain Syndrome (CRPS) Clinical Trial
TARGET Post-Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Complex Regional Pain Syndrome (CRPS) Clinical Trial
TARGET Post-Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Complex Regional Pain Syndrome (CRPS) Clinical Trial
TARGET Post-Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
Status: Enrolling,
Phase
III
Updated: 1/5/2018
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
Status: Enrolling,
Phase
III
Updated: 1/5/2018
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
Status: Enrolling,
Phase
III
Updated: 1/5/2018
Click here to add this to my saved trials
Broad Solid Tumor Clinical Trial
An Investigational Immuno-therapy Study to Evaluate the Safety and Effectiveness of Experimental Medication BMS-986207 by Itself and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Musculoskeletal, Rheumatology Clinical Trial
PEACE: Comparing Chronic Pain Treatment Options
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Urothelial Cancer Clinical Trial
Updated: 12/31/1969
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Observational Study of Obstructive Lung Disease (NOVELTY)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Updated: 12/31/1969
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Updated: 12/31/1969
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Volunteers Clinical Trial
Updated: 12/20/2016
A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.
Status: Enrolling,
Phase
I
Updated: 12/20/2016
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment Resistant Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
Standardized Treatment of Pulmonary Exacerbations II
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Complex Regional Pain Syndrome (CRPS) Clinical Trial
Updated: 12/31/1969
TARGET Post-Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Complex Regional Pain Syndrome (CRPS) Clinical Trial
Updated: 12/31/1969
TARGET Post-Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Complex Regional Pain Syndrome (CRPS) Clinical Trial
Updated: 12/31/1969
TARGET Post-Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Complex Regional Pain Syndrome (CRPS) Clinical Trial
Updated: 12/31/1969
TARGET Post-Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Updated: 1/5/2018
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
Status: Enrolling,
Phase
III
Updated: 1/5/2018
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Updated: 1/5/2018
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
Status: Enrolling,
Phase
III
Updated: 1/5/2018
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Updated: 1/5/2018
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
Status: Enrolling,
Phase
III
Updated: 1/5/2018
Click here to add this to my saved trials
Broad Solid Tumor Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study to Evaluate the Safety and Effectiveness of Experimental Medication BMS-986207 by Itself and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Musculoskeletal, Rheumatology Clinical Trial
Updated: 12/31/1969
PEACE: Comparing Chronic Pain Treatment Options
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials